These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 10607586)

  • 1. The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis.
    Powell WC; Fingleton B; Wilson CL; Boothby M; Matrisian LM
    Curr Biol; 1999 Dec 16-30; 9(24):1441-7. PubMed ID: 10607586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligand.
    Vargo-Gogola T; Crawford HC; Fingleton B; Matrisian LM
    Arch Biochem Biophys; 2002 Dec; 408(2):155-61. PubMed ID: 12464266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of membrane and soluble forms of Fas ligand and of matrilysin (MMP-7) activity in normal and abnormal human semen.
    Riccioli A; Dal Secco V; De Cesaris P; Starace D; Gandini L; Lenzi A; Dondero F; Padula F; Filippini A; Ziparo E
    Hum Reprod; 2005 Oct; 20(10):2814-20. PubMed ID: 15979995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis.
    Fingleton B; Vargo-Gogola T; Crawford HC; Matrisian LM
    Neoplasia; 2001; 3(6):459-68. PubMed ID: 11774028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of metalloproteinase cleavage enhances the cytotoxicity of Fas ligand.
    Knox PG; Milner AE; Green NK; Eliopoulos AG; Young LS
    J Immunol; 2003 Jan; 170(2):677-85. PubMed ID: 12517928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrilysin (matrix metalloproteinase-7) selects for apoptosis-resistant mammary cells in vivo.
    Vargo-Gogola T; Fingleton B; Crawford HC; Matrisian LM
    Cancer Res; 2002 Oct; 62(19):5559-63. PubMed ID: 12359768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of autoimmune diabetes by Fas ligand: the paradox is solved.
    Kim S; Kim KA; Hwang DY; Lee TH; Kayagaki N; Yagita H; Lee MS
    J Immunol; 2000 Mar; 164(6):2931-6. PubMed ID: 10706679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix Metalloproteinases Retain Soluble FasL-mediated Resistance to Cell Death in Fibrotic-Lung Myofibroblasts.
    Nareznoi D; Konikov-Rozenman J; Petukhov D; Breuer R; Wallach-Dayan SB
    Cells; 2020 Feb; 9(2):. PubMed ID: 32053892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of tumour cell apoptosis by matrix metalloproteinase inhibitors: new tricks from a (not so) old drug.
    Mitsiades N; Poulaki V; Mitsiades CS; Anderson KC
    Expert Opin Investig Drugs; 2001 Jun; 10(6):1075-84. PubMed ID: 11772236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity.
    Mitsiades N; Yu WH; Poulaki V; Tsokos M; Stamenkovic I
    Cancer Res; 2001 Jan; 61(2):577-81. PubMed ID: 11212252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrilysin inhibits proliferation and modulates sensitivity of lung cancer cells to FasL-mediated apoptosis.
    Liu H; Huang J; Wu B; Zhou Y; Zhu J; Zhang T
    Med Oncol; 2008; 25(4):419-30. PubMed ID: 18340552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fas ligand is constitutively secreted by prostate cancer cells in vitro.
    Liu QY; Rubin MA; Omene C; Lederman S; Stein CA
    Clin Cancer Res; 1998 Jul; 4(7):1803-11. PubMed ID: 9676859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fas ligand exerts its pro-inflammatory effects via neutrophil recruitment but not activation.
    Dupont PJ; Warrens AN
    Immunology; 2007 Jan; 120(1):133-9. PubMed ID: 17233740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas ligand/Fas-mediated apoptosis in human coronary artery smooth muscle cells: therapeutic implications of fratricidal mode of action.
    Belanger AJ; Scaria A; Lu H; Sullivan JA; Cheng SH; Gregory RJ; Jiang C
    Cardiovasc Res; 2001 Sep; 51(4):749-61. PubMed ID: 11530108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis-inducing membrane vesicles. A novel agent with unique properties.
    Jodo S; Xiao S; Hohlbaum A; Strehlow D; Marshak-Rothstein A; Ju ST
    J Biol Chem; 2001 Oct; 276(43):39938-44. PubMed ID: 11546786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS).
    Matute-Bello G; Liles WC; Steinberg KP; Kiener PA; Mongovin S; Chi EY; Jonas M; Martin TR
    J Immunol; 1999 Aug; 163(4):2217-25. PubMed ID: 10438964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fas mediates apoptosis and oxidant-induced cell death in cultured hRPE cells.
    Jiang S; Wu MW; Sternberg P; Jones DP
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):645-55. PubMed ID: 10711676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane-bound Fas ligand only is essential for Fas-induced apoptosis.
    O' Reilly LA; Tai L; Lee L; Kruse EA; Grabow S; Fairlie WD; Haynes NM; Tarlinton DM; Zhang JG; Belz GT; Smyth MJ; Bouillet P; Robb L; Strasser A
    Nature; 2009 Oct; 461(7264):659-63. PubMed ID: 19794494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity.
    Schneider P; Holler N; Bodmer JL; Hahne M; Frei K; Fontana A; Tschopp J
    J Exp Med; 1998 Apr; 187(8):1205-13. PubMed ID: 9547332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Fas/Fas ligand-mediated apoptotic cell death of lymphocytes in vitro by circulating anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus.
    Suzuki N; Ichino M; Mihara S; Kaneko S; Sakane T
    Arthritis Rheum; 1998 Feb; 41(2):344-53. PubMed ID: 9485093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.